Search results
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Reuters· 22 hours ago, opens new tab Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes...
New Analysis Confirms Wegovy Can Sustain Weight Loss for 4 Years and Support Heart Health
Verywell Health via Yahoo News· 3 days agoIn the meantime, she said the current studies indicate that some patients may not need to take the...
Novo’s Ozempic slashes risk of death in kidney disease study
San Francisco Chronicle· 19 hours agoNovo Nordisk A/S’s blockbuster diabetes drug Ozempic cut patients’ risk of dying in a kidney-disease...
Growing Number of Americans Are Trying Weight-Loss Drugs
Homenewshere.com· 2 days agoGrowing , Number of Americans Are Trying , Weight-Loss Drugs. According to a recent poll, six...
Weight-loss drugs reduce kidney complication risks: Study
The Hill via Yahoo News· 16 hours agoThe active ingredient in Ozempic and Wegovy may help reduce the risk of kidney failure in those with...
Thinking About Trying Mounjaro? Here's What You Can Expect Week by Week
Parade· 2 days agoObesity specialists give realistic expectations of what to expect on a typical Mounjaro journey. ...
Novo Nordisk’s Ozempic slows diabetic kidney disease progression in trial
KFGO· 22 hours agoBy Nancy Lapid (Reuters) - Novo Nordisk's Ozempic slowed the worsening of kidney dysfunction in...
Mapped: U.S states that want Ozempic the most
Consumer Affairs· 2 days agoMany Americans want to take Ozempic. People in some states want the weight-loss drug even more. Massachusetts, New York and New Jersey ...
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking...
Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety...
Benzinga· 3 days agoAustralia announced on Wednesday that it would ban compounded versions of weight-loss drugs like...